These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7246250)

  • 21. Prevalence of human immunodeficiency virus infection: its impact on the diagnostic yields in exudative pleural effusions at the Kenyatta National Hospital, Nairobi.
    Owino EA; McLigeyo SO; Gathua SN; Nyong'o A
    East Afr Med J; 1996 Sep; 73(9):575-8. PubMed ID: 8991236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-malignant cells in pleural fluid].
    Zsiray M; Lukács J; Appel J; Lantos A; Szondy K
    Orv Hetil; 1995 Jan; 136(1):27-30. PubMed ID: 7845663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cells in serous effusions.
    Boddington MM
    Acta Cytol; 1980; 24(5):470. PubMed ID: 6159761
    [No Abstract]   [Full Text] [Related]  

  • 24. [Numerical alteration of chromosome 8 in pleural effusions].
    Ning J; Liu S; Cheng S
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):8-10. PubMed ID: 11776609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytologic changes in pleural neoplastic effusions treated by local chemotherapy (author's transl)].
    Cava E; Marsan C; Accard JL; Babo P; Lemaire G
    Arch Anat Cytol Pathol; 1980; 28(6):350-4. PubMed ID: 7458425
    [No Abstract]   [Full Text] [Related]  

  • 26. Lupus erythematosus cells in pleural effusions: diagnostic of systemic lupus erythematosus?
    Chao TY; Huang SH; Chu CC
    Acta Cytol; 1997; 41(4):1231-3. PubMed ID: 9250324
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytogenetic study of malignant and benign effusions.
    Musilová J; Michalová K; Dvorák O; Slavík S; Mĕricka O; Novotná J
    Neoplasma; 1981; 28(4):463-71. PubMed ID: 7290268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
    Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
    Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic work-up of pleural effusions.
    Froudarakis ME
    Respiration; 2008; 75(1):4-13. PubMed ID: 18185024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo.
    Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA
    J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of immunophenotype of lymphoid cells isolated from malignant pleural effusions.
    Jezewska E; Sikora J; Słowik-Gabryelska A; Zeromski J
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):51-6. PubMed ID: 8239908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of human telomerase reverse transcriptase mRNA of cells in pleural fluid by two-step in situ hybridization using digoxin-labeled oligonucleotide probes].
    Shu J; Sun GY; Liu AP; Liu J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):771-4. PubMed ID: 15257899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
    Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
    Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
    Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
    Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
    Cornfield DB; Gheith SM
    Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of ploidy, AgNOR and immunocytochemistry for differentiating benign and malignant cells in serous effusions.
    Palaoro LA; Blanco AM; Gamboni M; Rocher AE; Rotenberg RG
    Cytopathology; 2007 Feb; 18(1):33-9. PubMed ID: 17250601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of c-Ha-ras oncogene expression in pleural and peritoneal smear effusions by in situ hybridization.
    Athanassiadou PP; Veneti SZ; Kyrkou KA; Athanassiades PH
    Cancer Detect Prev; 1993; 17(6):585-90. PubMed ID: 8275510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH; Kim GE; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.